BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31255696)

  • 21. Fluorescently Labeled α-Conotoxin TxID, a New Probe for α3β4 Neuronal Nicotinic Acetylcholine Receptors.
    Huang M; Zhu X; Yang Y; Tan Y; Luo S; Zhangsun D
    Mar Drugs; 2022 Aug; 20(8):. PubMed ID: 36005514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-Function Elucidation of a New α-Conotoxin, MilIA, from
    Peigneur S; Devi P; Seldeslachts A; Ravichandran S; Quinton L; Tytgat J
    Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31527432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
    Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
    Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.
    Azam L; Maskos U; Changeux JP; Dowell CD; Christensen S; De Biasi M; McIntosh JM
    FASEB J; 2010 Dec; 24(12):5113-23. PubMed ID: 20739611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of a potent and selective α3β4 nicotinic acetylcholine receptor antagonist from an α-conotoxin synthetic combinatorial library.
    Chang YP; Banerjee J; Dowell C; Wu J; Gyanda R; Houghten RA; Toll L; McIntosh JM; Armishaw CJ
    J Med Chem; 2014 Apr; 57(8):3511-21. PubMed ID: 24649848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations.
    Katz D; DiMattia MA; Sindhikara D; Li H; Abraham N; Leffler AE
    Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34202022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor.
    Luo S; Akondi KB; Zhangsun D; Wu Y; Zhu X; Hu Y; Christensen S; Dowell C; Daly NL; Craik DJ; Wang CI; Lewis RJ; Alewood PF; Michael McIntosh J
    J Biol Chem; 2010 Apr; 285(16):12355-66. PubMed ID: 20145249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
    Kompella SN; Hung A; Clark RJ; Marí F; Adams DJ
    J Biol Chem; 2015 Jan; 290(2):1039-48. PubMed ID: 25411242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, Activity, and Application of Fluorescent Analogs of [D1G, Δ14Q]LvIC Targeting α6β4 Nicotinic Acetylcholine Receptor.
    Pei S; Xu C; Tan Y; Wang M; Yu J; Zhangsun D; Zhu X; Luo S
    Bioconjug Chem; 2023 Dec; 34(12):2194-2204. PubMed ID: 37748043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
    McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
    J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic Residues at Position 11 of α-Conotoxin LvIA Influence Subtype Selectivity between α3β2 and α3β4 Nicotinic Receptors via an Electrostatic Mechanism.
    Haufe Y; Kuruva V; Samanani Z; Lokaj G; Kamnesky G; Shadamarshan P; Shahoei R; Katz D; Sampson JM; Pusch M; Brik A; Nicke A; Leffler AE
    ACS Chem Neurosci; 2023 Dec; 14(24):4311-4322. PubMed ID: 38051211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational and Functional Mapping of Human and Rat α6β4 Nicotinic Acetylcholine Receptors Reveals Species-Specific Ligand-Binding Motifs.
    Hone AJ; Kaas Q; Kearns I; Hararah F; Gajewiak J; Christensen S; Craik DJ; McIntosh JM
    J Med Chem; 2021 Feb; 64(3):1685-1700. PubMed ID: 33523678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylcholine promotes binding of α-conotoxin MII at α3 β2 nicotinic acetylcholine receptors.
    Sambasivarao SV; Roberts J; Bharadwaj VS; Slingsby JG; Rohleder C; Mallory C; Groome JR; McDougal OM; Maupin CM
    Chembiochem; 2014 Feb; 15(3):413-24. PubMed ID: 24420650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning, Synthesis and Functional Characterization of a Novel α-Conotoxin Lt1.3.
    Chen J; Liang L; Ning H; Cai F; Liu Z; Zhang L; Zhou L; Dai Q
    Mar Drugs; 2018 Mar; 16(4):. PubMed ID: 29614714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Selectivity of an α-Conotoxin LvIA Analogue for α3β2 Nicotinic Acetylcholine Receptors Is Mediated by β2 Functionally Important Residues.
    Zhu X; Pan S; Xu M; Zhang L; Yu J; Yu J; Wu Y; Fan Y; Li H; Kasheverov IE; Kudryavtsev DS; Tsetlin VI; Xue Y; Zhangsun D; Wang X; Luo S
    J Med Chem; 2020 Nov; 63(22):13656-13668. PubMed ID: 33196189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.
    Wang S; Zhao C; Liu Z; Wang X; Liu N; Du W; Dai Q
    Mar Drugs; 2015 May; 13(6):3259-75. PubMed ID: 26023835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of α3β2β4 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists.
    Hone AJ; Rueda-Ruzafa L; Gordon TJ; Gajewiak J; Christensen S; Dyhring T; Albillos A; McIntosh JM
    J Neurochem; 2020 Jul; 154(2):158-176. PubMed ID: 31967330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
    Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
    Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A short framework-III (mini-M-2) conotoxin from the venom of a vermivorous species, Conus archon, inhibits human neuronal nicotinic acetylcholine receptors.
    Hernández-Sámano AC; Falcón A; Zamudio F; Michel-Morfín JE; Landa-Jaime V; López-Vera E; Jeziorski MC; Aguilar MB
    Peptides; 2022 Jul; 153():170785. PubMed ID: 35307452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.
    Luo S; Kulak JM; Cartier GE; Jacobsen RB; Yoshikami D; Olivera BM; McIntosh JM
    J Neurosci; 1998 Nov; 18(21):8571-9. PubMed ID: 9786965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.